Advertisement

Topics

Innovative Public-Private Consortium Established To Define The Triggers Of Inflammatory Bowel Disease

16:26 EDT 17 Jun 2017 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
SPRING HOUSE, Pa., May 5, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today the establishment of a Cooperative Research and Development Agreement (CRADA) with the Naval Medical Research Center (NMRC), Prometheus La...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Innovative Public-Private Consortium Established To Define The Triggers Of Inflammatory Bowel Disease"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...